Avatrombopag is a small-molecule thrombopoietin receptor agonist that increases platelet counts. It is a pharmaceutical raw material used in the manufacturing of oral formulations for patients with thrombocytopenia associated with chronic liver disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 570406-98-3
Avatrombopag maleate
pharmaceutical raw material
Ethyl 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylate
research compound
Lusutrombopag
pharmaceutical raw material
Eltrombopag Amide
pharmaceutical raw material
Eltrombopag olamine
pharmaceutical raw material
Desflurane
pharmaceutical raw material
6-Ketoestradiol
pharmaceutical raw material
4-[(4-Methyl-4-oxo-4λ⁵-piperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide
pharmaceutical raw material
1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]-2-pyridinyl]piperidine-4-carboxylic acid
OFZJKCQENFPZBH-UHFFFAOYSA-N
C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl